SCHEMBL8250283

SCHEMBL8250283

COC(=O)c1cc(OC)c(Oc2cccc3c2nc(N)n3C)c(OC)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 4/20 0.51
ITGAV P06756 4/20 0.51
SMN1; SMN2 Q16637 3/20 0.42
TSHR P16473 1/20 0.42
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
TLR8 Q9NR97 1/20 0.41
TUBB4A P04350 1/20 0.40
TUBB P07437 1/20 0.40
TUBA3C P0DPH7 1/20 0.40
TUBA1B P68363 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8043860 0.90 ITGB3 (0.52) ITGB3ITGAVSMN1; SMN2TSHRHDAC3
SCHEMBL8250421 0.89 ITGB3 (0.51) ITGB3ITGAVTLR8NPC1RAB9A
SCHEMBL8042662 0.83 ITGB3 (0.73) ITGB3ITGAVSMN1; SMN2TSHR
SCHEMBL8047151 0.80 ITGB3 (0.59) ITGB3ITGAVSMN1; SMN2TSHRTLR8
SCHEMBL8043750 0.80 ITGB3 (0.49) ITGB3ITGAV
SCHEMBL3860530 0.78 TLR8 (0.61) ITGB3ITGAVSMN1; SMN2TLR8NPC1
SCHEMBL8044809 0.76 ITGB3 (0.46) ITGB3ITGAV
SCHEMBL8032379 0.75 ITGB3 (0.46) ITGB3ITGAV
SCHEMBL8033060 0.74 ITGB3 (0.75) ITGB3ITGAVSMN1; SMN2TSHRNPC1
SCHEMBL11947882 0.74 PARP1 (0.48) ITGB3ITGAVTSHRTLR8LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007001249-A1 NITROGEN HETEROCYCLE BIARYLS FOR OSTEOPOROSIS AND OTHER DISEASES PHARMACOPEIA, INC. (US) 2007-01-04 WO disclosed